Drive Summary:

• Abbott Laboratories was ordered to pay $700 million to the Virginia Medicaid Fraud Control Unit on Monday by a U.S. District Court judge in Virginia.
• The fines comes from Abbott pleading guilty to a criminal misdemeanor charge in May.
• Abbott marketed the drug Depakote for uses not approved as effective and safe by the U.S. Food and Drug Administration

From the article:

The ruling also required Abbott to enter into a five-year probationary period. As a result, every year Abbott's CEO and board of directors will need to personally certify that the company is complying with the law.

Abbott has also agreed to enter a five-year corporate integrity agreement with the Office of the Department of Health and Human Services that requires enhanced accountability and transparency, as well as monitoring activities conducted by internal and independent external reviewers. ...